genialis

Imagenomix

The company develops an artificial intelligence platform that predicts cancer mutations from pathology images for healthcare providers and biopharma companies.

GeneCentric

This company develops gene expression-based liquid biopsy platforms and biomarkers to help pharmaceutical and diagnostic firms identify cancer treatment responders.

1Cell.Ai

The company develops single-cell multi-omic analysis platforms for oncology researchers and drug developers to monitor therapies, discover biomarkers, and study tumour heterogeneity.

StratifAI

This company develops multimodal artificial intelligence biomarkers to predict cancer recurrence risks from pathology slides for oncologists and pharmaceutical organisations.

Genassis

Genassis provides an artificial intelligence platform centralising regulatory, clinical and commercial data for life sciences and healthcare professionals.

Envisagenics

This biotechnology company develops an artificial intelligence platform to identify drug targets from RNA splicing data for pharmaceutical and biopharmaceutical organisations.

ViewsML

This company develops an artificial intelligence platform providing virtual biomarker staining of pathology images for biopharmaceutical researchers, clinical trial teams and diagnostic laboratories.

geninus

This company provides genomic analysis solutions and single-cell diagnostic platforms for pharmaceutical firms, healthcare providers and clinical researchers to enable precision medicine.